CIE-10

CIE-10-código C41

You are here: Inicio > CIE-10 > C00-D49 > C00-C97 > C00-C75 > C40-C41

- CIE-10
Clasificación Internacional de Enfermedades
- C00-D49
Tumores [neoplasias]
- C00-C97
Tumores [neoplasias] malignos
- C00-C75
y afines
- C40-C41
Tumores malignos de los huesos y de los cartílagos articulares

C41

Tumor maligno de los huesos y de los cartílagos articulares, de otros sitios y de sitios no especificados

CIE-10 Сódigo C41 para Tumor maligno de los huesos y de los cartílagos articulares, de otros sitios y de sitios no especificados

Excluye: cartílago (de los, de la)

• laríngeo (C32.3)

• miembros (C40.–)

• nariz (C30.0)

• oreja (C49.0)

huesos de los miembros (C40.–)

C41.0
Tumor maligno de los huesos del cráneo y de la cara
C41.1
Tumor maligno del hueso del maxilar inferior
C41.2
Tumor maligno de la columna vertebral
C41.3
Tumor maligno de la costilla, esternón y clavícula
C41.4
Tumor maligno de los huesos de la pelvis, sacro y cóccix
C41.8
Lesión de sitios contiguos del hueso y del cartílago articular
C41.9
Tumor maligno del hueso y del cartílago articular, no especificado
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us